Skip to main content Accessibility help
×
Home
Hostname: page-component-768ffcd9cc-5rkl9 Total loading time: 0.487 Render date: 2022-12-01T18:05:29.454Z Has data issue: true Feature Flags: { "shouldUseShareProductTool": true, "shouldUseHypothesis": true, "isUnsiloEnabled": true, "useRatesEcommerce": false, "displayNetworkTab": true, "displayNetworkMapGraph": false, "useSa": true } hasContentIssue true

Prescription drug co-payments and cost-related medication underuse

Published online by Cambridge University Press:  01 January 2008

TODD H. WAGNER*
Affiliation:
Department of Veterans Affairs Health Economics Resource Center, Department of Health Research and Policy, Stanford University, USA
MICHELE HEISLER
Affiliation:
Department of Veterans Affairs Center for Practice Management and Outcomes Research, Department of Internal Medicine, University of Michigan, Ann Arbor, USA
JOHN D. PIETTE
Affiliation:
Department of Veterans Affairs Center for Practice Management and Outcomes Research, Department of Internal Medicine, University of Michigan, Ann Arbor, USA
*
*Correspondence to: Todd H. Wagner, VA Palo Alto, 795 Willow Rd. (MPD-152), Menlo Park, CA 94025, USA. Email: twagner@stanford.edu

Abstract

Co-payments have been linked to the slowing growth in pharmaceutical spending over the last five years. However, patients with health problems frequently have difficulty affording their pharmacotherapy and fail to take their medication as prescribed. We examine the relationship between co-payment amounts and four types of cost-related underuse: taking fewer doses, postponing taking a medication, failing to fill a prescription at all, and taking medication less frequently than prescribed. We conducted a nationwide survey of US adults age 50 and over who take medication for a chronic condition. Participants provided information on 17 chronic conditions, medication they take for those conditions, and whether they underused any medication due to cost. We analyzed those who reported paying co-payments for their prescriptions (n = 2,869). Analysis involved multivariate logistic regression, with adjustments for survey weights and clustering. Our data show a strong positive association between co-payments and cost-related medication underuse. Although people differ in how they underuse medications, these behaviours are strongly associated with co-payment amount. Realigning the co-payments with cost-effectiveness data, also known as value-based insurance design, warrants further investigation.

Type
Articles
Copyright
Copyright © Cambridge University Press 2008

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Baker, L., Wagner, T. H., Singer, S. and Bundorf, M. K. (2003), ‘Use of the internet and e-mail for health care information: results from a national survey’, Journal of the American Medical Association, 289(18): 24002406.CrossRefGoogle Scholar
Bhandari, A. and Wagner, T., (2006), ‘Self-reported utilization of health care services: improving measurement and accuracy’, Medical Care Research and Review, 63(2): 217235.CrossRefGoogle Scholar
Catlin, A., Cowan, C., Heffler, S., and Washington, B., (2007), ‘National health spending in 2005: the slowdown continues’, Health Affairs (Millwood), 26(1): 142153.CrossRefGoogle Scholar
Choo, P. W., Rand, C. S., Inui, T. S., Lee, M. L., Cain, E., Cordeiro-Breault, M., Canning, C., and Platt, R., (1999), ‘Validation of patient reports, automated pharmacy records, and pill counts with electronic monitoring of adherence to antihypertensive therapy’, Medical Care, 37(9): 846857.CrossRefGoogle Scholar
Evans, C. and Crawford, B., (1999), ‘Patient self-reports in pharmacoeconomic studies: their use and impact on study validity’, Pharmacoeconomics, 15(3): 241256.CrossRefGoogle Scholar
Fendrick, A. M., Smith, D. G., Chernew, M. E., and Shah, S. N. (2001), ‘A benefit-based copay for prescription drugs: patient contribution based on total benefits, not drug acquisition cost’, American Journal of Managed Care, 7(9): 861867.Google ScholarPubMed
Goldman, D. P., Joyce, G. F., Escarce, J. J., Pace, J. E., Solomon, M. D., Laouri, M., Landsman, P. B., and Teutsch, S. M. (2004), ‘Pharmacy benefits and the use of drugs by the chronically ill’, Journal of the American Medical Association, 291(19): 23442350.CrossRefGoogle Scholar
Goldman, D. P., Joyce, G. F., and Karaca-Mandic, P. (2006), ‘Varying pharmacy benefits with clinical status: the case of cholesterol-lowering therapy’, American Journal of Managed Care, 12(1): 2128.Google Scholar
Goldman, D. P. and Lakdawalla, D. (2002), ‘A new method for determining patient payments for outpatient drugs’, American Journal of Managed Care, 8(2): 125, 128, 130.Google Scholar
Harris, K. M. (2002), ‘Can high quality overcome consumer resistance to restricted provider access? Evidence from a health plan choice experiment’, Health Services Research, 37(3): 551571.CrossRefGoogle Scholar
Heisler, M., Wagner, T. H., and Piette, J. D. (2004), ‘Clinician identification of chronically ill patients who have problems paying for prescription medications’, American Journal of the Medical Sciences, 116(11): 753758.Google Scholar
Heisler, M., Wagner, T. H., and Piette, J. D. (2005), ‘Patient strategies to cope with high prescription medication costs: who is cutting back on necessities, increasing debt, or underusing medications?’, Journal of Behavioral Medicine, 28(1): 4351.CrossRefGoogle ScholarPubMed
Hsu, J., Price, M., Huang, J., Brand, R., Fung, V., Hui, R., Fireman, B., Newhouse, J. P., and Selby, J. V. (2006), ‘Unintended consequences of caps on Medicare drug benefits’, New England Journal of Medicine, 354(22): 23492359.CrossRefGoogle Scholar
Huskamp, H. A., Deverka, P. A., Epstein, A. M., Epstein, R. S., McGuigan, K. A. and Frank, R. G. (2003), ‘The effect of incentive-based formularies on prescription-drug utilization and spending’, New England Journal of Medicine, 349(23): 22242232.CrossRefGoogle Scholar
Kleinke, J. D. (2004), ‘Access versus excess: value-based cost sharing for prescription drugs’, Health Affairs (Millwood), 23(1): 3447.CrossRefGoogle Scholar
Melfi, C. A., Chawla, A. J., Croghan, T. W., Hanna, M. P., Kennedy, S., and Sredl, K. (1998), ‘The effects of adherence to antidepressant treatment guidelines on relapse and recurrence of depression’, Archives of General Psychiatry, 55(12): 11281132.CrossRefGoogle Scholar
MMWR (2000), ‘HIV-related knowledge and stigma–United States, 2000’, MMWR Morbidity and Mortality Weekly Report, 49(47): 10621064.Google Scholar
Mojtabai, R. and Olfson, M. (2003), ‘Medication costs, adherence, and health outcomes among Medicare beneficiaries’, Health Affairs (Millwood), 22(4): 220229.CrossRefGoogle Scholar
Neumann, P. J., Lin, P. J., Greenberg, D., Berger, M., Teutsch, S., Mansley, E., Weinstein, M. C., and Rosen, A. B. (2006), ‘Do drug formulary policies reflect evidence of value?’, American Journal of Managed Care, 12(1): 3036.Google Scholar
Piette, J. D., Heisler, M., Krein, S., and Kerr, E. A. (2005), ‘The role of patient–physician trust in moderating medication nonadherence due to cost pressures’, Archives of Internal Medicine, 165(15): 17491755.CrossRefGoogle Scholar
Piette, J. D., Heisler, M., and Wagner, T. H. (2004), ‘Cost-related medication underuse among chronically ill adults: the treatments people forgo, how often, and who is at risk’, American Journal of Public Health, 94(10): 17821787.CrossRefGoogle Scholar
Piette, J. D., Heisler, M., and Wagner, T. H. (2004), ‘Cost-related medication underuse: do patients with chronic illnesses tell their doctors?’, Archives of Internal Medicine, 164(16): 17491755.CrossRefGoogle Scholar
Piette, J. D., Heisler, M., and Wagner, T. H. (2004), ‘Problems paying out-of-pocket medication costs among older adults with diabetes’, Diabetes Care, 27(2): 384391.CrossRefGoogle Scholar
Piette, J. D., Heisler, M., and Wagner, T. H. (2006), ‘Medication characteristics beyond cost alone influence decisions to underuse pharmacotherapy in response to financial pressures’, Journal of Clinical Epidemiology, 59(7): 739746.CrossRefGoogle Scholar
Roblin, D. W., Platt, R., Goodman, M. J., Hsu, J., Nelson, W. W., Smith, D. H., Andrade, S. E., and Soumerai, S. B. (2005), ‘Effect of increased cost-sharing on oral hypoglycemic use in five managed care organizations: how much is too much?’, Medical Care, 43(10): 951959.CrossRefGoogle Scholar
Rosen, A. B. (2006), ‘Grounding coverage in value: a paradigm for linking quality and costs’, Medical Care, 44(5): 389391.CrossRefGoogle Scholar
Soumerai, S. B., Avorn, J., Ross-Degnan, D., and Gortmaker, S. (1987), ‘Payment restrictions for prescription drugs under Medicaid: effects on therapy, cost, and equity’, New England Journal of Medicine, 317(9): 550556.CrossRefGoogle Scholar
Soumerai, S. B., McLaughlin, T. J., Ross-Degnan, D., Casteris, C. S., and Bollini, P. (1994), ‘Effects of a limit on Medicaid drug-reimbursement benefits on the use of psychotropic agents and acute mental health services by patients with schizophrenia’, New England Journal of Medicine, 331(10): 650655.CrossRefGoogle Scholar
Soumerai, S. B., Ross-Degnan, D., Avorn, J., McLaughlin, T., and Choodnovskiy, I. (1991), ‘Effects of Medicaid drug-payment limits on admission to hospitals and nursing homes’, New England Journal of Medicine, 325(15): 10721077.CrossRefGoogle Scholar
Steiner, J. F. and Prochazka, A. V. (1997), ‘The assessment of refill compliance using pharmacy records: methods, validity, and applications’, Journal of Clinical Epidemiology, 50(1): 105116.CrossRefGoogle Scholar
Steinman, M. A., Sands, L. P., and Covinsky, K. E. (2001), ‘Self-restriction of medications due to cost in seniors without prescription coverage’, Journal of General Internal Medicine, 16(12): 793799.CrossRefGoogle Scholar
Tamblyn, R., Laprise, R., Hanley, J. A., Abrahamowicz, M., Scott, S., Mayo, N., Hurley, J., Grad, R., Latimer, E., Perreault, R., McLeod, P., Huang, A., Larochelle, P., and Mallet, L. (2001), ‘Adverse events associated with prescription drug cost-sharing among poor and elderly persons’, Journal of the American Medical Association, 285(4): 421429.CrossRefGoogle Scholar
WareJ., Jr. J., Jr., Kosinski, M., and Keller, S. D. (1996), ‘A 12-Item short-form health survey: construction of scales and preliminary tests of reliability and validity’, Medical Care, 34(3): 220233.CrossRefGoogle Scholar
33
Cited by

Save article to Kindle

To save this article to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Prescription drug co-payments and cost-related medication underuse
Available formats
×

Save article to Dropbox

To save this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you used this feature, you will be asked to authorise Cambridge Core to connect with your Dropbox account. Find out more about saving content to Dropbox.

Prescription drug co-payments and cost-related medication underuse
Available formats
×

Save article to Google Drive

To save this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you used this feature, you will be asked to authorise Cambridge Core to connect with your Google Drive account. Find out more about saving content to Google Drive.

Prescription drug co-payments and cost-related medication underuse
Available formats
×
×

Reply to: Submit a response

Please enter your response.

Your details

Please enter a valid email address.

Conflicting interests

Do you have any conflicting interests? *